- Home
- WES vs RVMD Comparison
WES vs RVMD Comparison
Compare WES & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WES | RVMD |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3B | 15.2B |
| IPO Year | 2008 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WES | RVMD |
|---|---|---|
| Price | $40.51 | $97.52 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 17 |
| Target Price | $41.20 | ★ $77.47 |
| AVG Volume (30 Days) | 996.8K | ★ 2.9M |
| Earning Date | 02-25-2026 | 02-25-2026 |
| Dividend Yield | ★ 9.19% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.38 | N/A |
| Revenue | ★ $3,740,425,000.00 | N/A |
| Revenue This Year | $8.40 | N/A |
| Revenue Next Year | $6.96 | $714.50 |
| P/E Ratio | $11.72 | ★ N/A |
| Revenue Growth | ★ 5.81 | N/A |
| 52 Week Low | $33.60 | $29.17 |
| 52 Week High | $43.33 | $105.00 |
Technical Indicators
Market Signals| Indicator | WES | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 62.65 | 88.59 |
| Support Level | $39.45 | $76.28 |
| Resistance Level | $40.37 | $80.48 |
| Average True Range (ATR) | 0.56 | 4.87 |
| MACD | 0.06 | 2.13 |
| Stochastic Oscillator | 96.47 | 91.55 |
Price Performance
Historical ComparisonAbout WES Western Midstream Partners LP
Western Midstream Partners LP is a USA-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma), North-central Pennsylvania and Texas.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.